Description
Klow extends the Glow formulation with KPV, the Lys-Pro-Val tripeptide derived from alpha-MSH. Each vial holds 80 mg of total peptide across the four components: KPV, BPC-157, GHK-Cu and TB-500.
The rationale for the blend comes from separate lines of preclinical work. KPV has been investigated for NF-κB-related inflammatory signalling in epithelial and colitis models; BPC-157 and thymosin beta-4 fragments for cell migration and angiogenesis in rodent repair models; and GHK-Cu for extracellular-matrix synthesis in fibroblasts. Researchers use the blend to study these pathways in combination. As with any multi-component blend, single-peptide controls help attribute observed effects to a particular component.
Store sealed, cold and protected from light.
For laboratory research use only. This product is not a medicine, food or cosmetic and is not for human or veterinary use.
Supplied as a 10-vial kit of lyophilised powder. Dispatched in 1–2 business days.




